Natalizumab for active Crohn's disease.
Ghosh S, Goldin E, Gordon FH, Malchow HA, Rask-Madsen J, Rutgeerts P, Vyhnálek P, Zádorová Z, Palmer T, Donoghue S; Natalizumab Pan-European Study Group.
Ghosh S, et al. Among authors: donoghue s.
N Engl J Med. 2003 Jan 2;348(1):24-32. doi: 10.1056/NEJMoa020732.
N Engl J Med. 2003.
PMID: 12510039
Free article.
Clinical Trial.